Advertisement
Screener

NeuBase Therapeutics, Inc. Form D

NeuBase Therapeutics, Inc. Form D Notices of Exempt Offering of Securities

Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.

  • 2023-07-07: Federal exemption Rule 506(b); Types of securities offered Equity; OptionToAcquire; SecurityToBeAcquired; Date of first sale 2023-06-28; Total offering amount $5,000,002.
  • 2014-01-16: Federal exemption Rule 506(b); Types of securities offered OptionToAcquire; Date of first sale 2013-12-30; Total offering amount $569,581.
  • 2013-10-11: Federal exemption Rule 506(b); Types of securities offered Equity; OptionToAcquire; Date of first sale 2013-10-02; Total offering amount $376,915.
  • 2009-06-04: Federal exemption Rule 506; Types of securities offered Equity; OptionToAcquire; SecurityToBeAcquired; Date of first sale 2009-06-03; Total offering amount $1,080,000.
FiledFederal exemptionTypes of securities offeredDate of first saleTotal offering amountTotal amount soldTotal remaining to be soldInvestors who have already invested
2023-07-07Rule 506(b)Equity; OptionToAcquire; SecurityToBeAcquired2023-06-28$5,000,002$5,000,002$01
2014-01-16Rule 506(b)OptionToAcquire2013-12-30$569,581$569,581$03
2013-10-11Rule 506(b)Equity; OptionToAcquire2013-10-02$376,915$376,915$03
2009-06-04Rule 506Equity; OptionToAcquire; SecurityToBeAcquired2009-06-03$1,080,000$1,005,000$75,00024
2009-04-03Rule 506Debt; SecurityToBeAcquired2009-03-19$500,000$500,000$01